Has Kimberly Koval received payments from drug or device companies?

Yes. Drug and device makers reported $14,590 in general payments to Kimberly Koval across 412 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Koval did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Koval come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Koval

Adult Health · Springfield, NJNPI 1083987101

Payments from drug & device makers

$14,590in general payments, 2019–2025

Across 412 payments — averaging $35.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$3K
Genentech USA, Inc.$1K
Janssen Scientific Affairs, LLC$1K
AstraZeneca$1K
AbbVie$831
Incyte Corporation$756
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	57	$2,706
Genentech USA, Inc.	9	$1,500
Janssen Scientific Affairs, LLC	4	$1,462
AstraZeneca(2 entities)	21	$1,145
AbbVie	24	$831
Incyte Corporation	16	$756
Johnson & Johnson(2 entities)	26	$753
Pfizer	35	$635
GSK	26	$564
Amgen	10	$334
Merck	18	$330
Pharmacosmos Therapeutics Inc.	5	$289
E.r. Squibb & Sons, L.L.C.	10	$252
Bayer	8	$203
Beigene USA, Inc.	5	$201
Seagen Inc.	5	$179
Rigel Pharmaceuticals, Inc.	9	$162
Takeda Pharmaceuticals U.S.A., Inc.	7	$151
Daiichi Sankyo Inc.	9	$150
Lilly USA, LLC	8	$136
Regeneron Healthcare Solutions, Inc.	7	$121
Taiho Oncology, Inc.	6	$107
Pharmaessentia USA Corporation	6	$101
AVEO Pharmaceuticals, Inc.	1	$100
Astellas Pharma US Inc	5	$91
Abbott	3	$66
ADC Therapeutics America, Inc.	3	$64
Mirati Therapeutics, Inc.	3	$61
Blueprint Medicines Corporation	3	$56
Array Biopharma Inc	3	$56
Tersera Therapeutics LLC	3	$50
Gilead	3	$49
Stemline Therapeutics Inc.	3	$49
Servier Pharmaceuticals LLC	3	$48
Genmab U.S., Inc.	3	$47
Foundation Medicine, Inc.	1	$46
Adaptive Biotechnologies Corporation	2	$44
Beone Medicines USA, Inc.	2	$40
Eisai Inc.	2	$39
Macrogenics, Inc.	2	$38
Sobi, Inc	2	$37
EMD Serono, Inc.	2	$36
Agios Pharmaceuticals, Inc.	2	$35
Deciphera Pharmaceuticals Inc.	2	$34
Morphosys, US Inc.	2	$31
Geron Corporation	2	$31
Bristol Myers Squibb	2	$30
CTI Biopharma Corp.	2	$29
Jazz Pharmaceuticals Inc.	2	$28
Sanofi	1	$23
Azurity Pharmaceuticals, Inc.	1	$22
Springworks Therapeutics, Inc.	1	$21
Exelixis Inc.	1	$21
Tempus AI, Inc	1	$19
Puma Biotechnology, Inc.	1	$18
Immunocore Limited	1	$17
Ipsen Biopharmaceuticals, Inc	1	$17
Verastem, Inc.	1	$16
Axsome Therapeutics, Inc.	1	$15
AMAG Pharmaceuticals, Inc.	1	$15

How this compares

$14,590 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey →

Medicare billing

Part B allowed, 2024

$38,299

Medicare patients

334

Services billed

900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Springfield

June HalperHackensack$458K
Kara SaggiomoCamden$127K
Entela AhmetiPomona$75K
Phyllis McKiernanHackensack$72K
Denise ForceMiddletown$71K
Kathleen SenecaHillsborough$64K
Diane AndresenNorthvale$60K
Dana BeenstockFreehold$51K
Phyllis DudaCamden$46K
Anthony WalkoWestwood$34K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →